scholarly article | Q13442814 |
P356 | DOI | 10.1007/S10461-009-9611-5 |
P8608 | Fatcat ID | release_wwbj56gygbbqrlmjcvqrzlcgxy |
P932 | PMC publication ID | 2865630 |
P698 | PubMed publication ID | 19757017 |
P5875 | ResearchGate publication ID | 26814816 |
P50 | author | Ana Ventuneac | Q66370982 |
P2093 | author name string | Peter Anton | |
Charles Price | |||
Ian McGowan | |||
Alex Carballo-Diéguez | |||
Robert Dennis | |||
Amy Adler | |||
Elena Khanukhova | |||
Terry Saunders | |||
Chomchay Siboliban | |||
P2860 | cites work | Acceptability of a bioadhesive nonoxynol-9 gel delivered by an applicator as a rectal microbicide | Q73179863 |
Evaluating the clinical safety of three vaginal applicators: a pilot study conducted in the Dominican Republic | Q82051175 | ||
Frequent use of lubricants for anal sex among men who have sex with men: the HIV prevention potential of a microbicidal gel | Q24544056 | ||
Anal sex among HIV-seronegative women at high risk of HIV exposure. The HIVNET Vaccine Preparedness Study 2 Protocol Team | Q30233648 | ||
Rectal microbicides for U.S. gay men. Are clinical trials needed? Are they feasible? HIVNET Vaccine Preparedness Study Protocol Team | Q30233761 | ||
Assessing microbicide acceptability: a comprehensive and integrated approach. | Q30362581 | ||
Nonoxynol-9 causes rapid exfoliation of sheets of rectal epithelium | Q30637009 | ||
Per-contact risk of human immunodeficiency virus transmission between male sexual partners | Q33869711 | ||
Heterosexual anal intercourse: prevalence, cultural factors, and HIV infection and other health risks, Part I. | Q33879070 | ||
Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. | Q33956699 | ||
The use of rectal douches among HIV-uninfected and infected men who have unprotected receptive anal intercourse: implications for rectal microbicides | Q34191301 | ||
Awareness and attitudes regarding microbicides and Nonoxynol-9 use in a probability sample of gay men. | Q34538391 | ||
Women's anal sex practices: implications for formulation and promotion of a rectal microbicide | Q34773756 | ||
Microbicide acceptability research: current approaches and future directions | Q35937340 | ||
Preferences and practices related to vaginal lubrication: implications for microbicide acceptability and clinical testing | Q36179637 | ||
Preference for gel over suppository as delivery vehicle for a rectal microbicide: results of a randomised, crossover acceptability trial among men who have sex with men. | Q37159238 | ||
Anal intercourse among young heterosexuals in three sexually transmitted disease clinics in the United States | Q37249738 | ||
Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda | Q38885289 | ||
Safer sex knowledge, behavior, and attitudes of inner-city women | Q39406194 | ||
Preferences about the characteristics of future HIV prevention products among men who have sex with men. | Q39570244 | ||
Prevalence and correlates of anal sex with men among young adult women in an inner city minority neighborhood | Q39582066 | ||
Knowledge and acceptability of alternative HIV prevention bio-medical products among MSM who bareback | Q40123390 | ||
Heterosexual anal intercourse: an understudied, high-risk sexual behavior | Q41756478 | ||
Preclinical studies on thiocarboxanilide UC-781 as a virucidal agent. | Q42540870 | ||
A randomized six-day safety study of an antiretroviral microbicide candidate UC781, a non-nucleoside reverse transcriptase inhibitor. | Q44937054 | ||
Lubricants containing N-9 may enhance rectal transmission of HIV and other STIs | Q45003020 | ||
Prevalence of anal sex among heterosexuals in California and its relationship to other AIDS risk behaviors. | Q45978785 | ||
Anal intercourse among young low-income women in California: an overlooked risk factor for HIV? | Q46641305 | ||
National trends in condom use among at-risk heterosexuals in the united states | Q46858053 | ||
Anal Intercourse and Sexual Risk Factors Among College Women, 1993-2000 | Q46931161 | ||
Heterosexual anal sex activity in the year after an STD clinic visit | Q47411651 | ||
Safety and toxicity of nonoxynol-9 gel as a rectal microbicide. | Q52536992 | ||
Rectal microbicides: a new focus for HIV prevention. | Q55051111 | ||
High-risk behaviors among men who have sex with men in 6 US cities: baseline data from the EXPLORE Study | Q56897894 | ||
Sexual behavior and selected health measures: men and women 15-44 years of age, United States, 2002 | Q64131535 | ||
Rectal microbicide acceptability: results of a volume escalation trial. | Q65002886 | ||
P433 | issue | 3 | |
P304 | page(s) | 618-628 | |
P577 | publication date | 2009-09-11 | |
P1433 | published in | AIDS and Behavior | Q15752229 |
P1476 | title | Acceptability of UC781 gel as a rectal microbicide among HIV-uninfected women and men. | |
P478 | volume | 14 |
Q37066942 | A social ecology of rectal microbicide acceptability among young men who have sex with men and transgender women in Thailand |
Q36674543 | Acceptability of potential rectal microbicide delivery systems for HIV prevention: a randomized crossover trial |
Q36039442 | Assessing the potential of the Woman's Condom for vaginal drug delivery |
Q34302073 | Commercial lubricant use among HIV-negative men who have sex with men in Los Angeles: implications for the development of rectal microbicides for HIV prevention |
Q21135264 | First phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex vivo efficacy |
Q36034691 | Hypothetical Rectal Microbicide Acceptability and Factors Influencing It among Men Who Have Sex with Men in Tianjin, China |
Q33761194 | Increasing the effectiveness of vaginal microbicides: a biophysical framework to rethink behavioral acceptability |
Q36421478 | Influence of Partner Type on Acceptability and Likelihood of Use of a Rectal Microbicide Among Young Men Who Have Sex With Men in the United States and Puerto Rico |
Q55165951 | Lessons for Rectal Microbicide Development From an Acceptability Trial of a Placebo Gel Applied Prior to Receptive Anal Intercourse. |
Q40145771 | Lubricant Provides Poor Rectal Mucosal HIV Coverage. |
Q35770899 | Microbicides for HIV prevention |
Q39356290 | On-demand microbicide products: design matters |
Q46166943 | Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men. |
Q51835298 | Preparing for rectal microbicides: sociocultural factors affecting product uptake among potential South American users. |
Q46902763 | Prevalence and correlates of willingness to participate in a rectal microbicide trial among men who have sex with men in Bangkok |
Q87405838 | Rectal microbicide development |
Q34575590 | Rectal microbicide development. |
Q35012572 | Rectal microbicides: can we make them and will people use them? |
Q26829713 | Rectal pre-exposure prophylaxis (PrEP) |
Q35061678 | Rectal-specific microbicide applicator: evaluation and comparison with a vaginal applicator used rectally |
Q35323124 | Sexual behaviors and partner-specific correlates of heterosexual anal intercourse among truck drivers and their wives in South India |
Q30538073 | Shape of vaginal suppositories affects willingness-to-try and preference |
Q37932048 | Specific microbicides in the prevention of HIV infection |
Q35822713 | The rational design and development of a dual chamber vaginal/rectal microbicide gel formulation for HIV prevention. |
Q34030735 | Youth-specific considerations in the development of preexposure prophylaxis, microbicide, and vaccine research trials |
Search more.